You are here: Industry Insights > Novartis

News List

AbCellera and Novartis enter into multi-target partnership pharmaceutical-technology
February 15, 2019
Canada-based AbCellera has announced it has signed a multi-year, multi-target agreement with Novartis under which its antibody discovery technology will be leveraged by the Swiss pharma giant for up to ten clinically-relevant disease targets....
FDA Approves Egaten (triclabendazole) for the Treatment of Fascioliasis, a Neglected Tropical Disease drugs
February 14, 2019
Novartis announced today that the US Food and Drug Administration (FDA) has approved Egaten (triclabendazole) for the treatment of fascioliasis in patients six years of age and older....
Novartis to divest Proleukin’s US rights to Clinigen for $210m pharmaceutical-technology
February 14, 2019
Novartis has signed an agreement to divest the US rights to its Proleukin (aldesleukin) medicine to UK-based Clinigen Group for a total cash consideration of up to $210m.....
Novartis changes NICE's mind on Kymriah, giving CAR-T rival Gilead some company fiercepharma
February 01, 2019
Payer coverage is key to Novartis’ plan to get Kymriah going, and the company is going to be getting some more of that.
Government Of Ghana Partners Novartis To Improve Diagnosis, Treatment Of Sickle Cell Disease firstwordpharma
January 28, 2019
The Government of Ghana, through the Ministry of Health, Ghana Health Service and other allied agencies, signed a Memorandum of Understanding (MoU) with Novartis to create a partnership designed to improve the diagnoses and accelerate treatment for people
Novartis expresses concerns over no-deal Brexit firstwordpharma
January 28, 2019
Novartis on Friday called for the UK to take additional steps to ensure that drug supplies are not disrupted if the country leaves the EU without an exit agreement.
Novartis expresses concerns over no-deal Brexit firstwordpharma
January 28, 2019
Novartis on Friday called for the UK to take additional steps to ensure that drug supplies are not disrupted if the country leaves the EU without an exit agreement.
Novartis picks hackathon challengers, preps for final showdown at SXSW fiercepharma
January 23, 2019
Novartis' Sandoz unit is ready to hack at South by Southwest this spring. The three finalists from the Sandoz Healthcare Access Challenge (HACk) will hone and present their digital solutions during the spring event known for music, film and digital innova
Novartis and University of Oxford partner on AI-based drug development pharmaceutical-technology
January 22, 2019
Novartis has partnered with the University of Oxford’s Big Data Institute (BDI) to boost drug development using artificial intelligence (AI) and advanced analytics.....
Novartis chooses Kinaxis’ technology to improve supply chain planning pharmaceutical-technology
January 22, 2019
Canadian supply chain technology company Kinaxis has announced its RapidResponse platform has been selected by Novartis’s technical operations unit to help the drug maker improve its supply chain management....

Previous page 1 2 3 4 5 6 7 8 9 10 ... 71 72 Next page